Oak Associates’s Boston Scientific BSX Stock Holding History

Oak Associates’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-121,800	Closed	-$1.55M	–	183
2014 Q2	$1.55M	Sell	121,800 -62,000	-34%	-$806K	0.19%	99
2014 Q1	$2.48M	Sell	183,800 -9,000	-5%	-$118K	0.31%	72
2013 Q4	$2.32M	Buy	+192,800	New	+$2.28M	0.25%	72
2013 Q2	$1.95M	Buy	+210,800	New	+$1.79M	0.23%	73

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Oak Associates's BSX Position: Q3 2014 in Review

Oak Associates sold out of Boston Scientific (BSX) in Q3 2014, closing a stake of 121,800 shares — an estimated $1.55M sold.

Oak Associates first reported a position in BSX in Q2 2013 and held it in 4 quarters. The position peaked at $2.48M in Q1 2014. 436 funds tracked by Wall St. Rank hold BSX as of Q3 2014.

Oak Associates reported no remaining Boston Scientific position as of Q3 2014 after selling out during the quarter.
Oak Associates sold 121,800 Boston Scientific shares in Q3 2014, an estimated $1.55M.
Oak Associates first reported a position in Boston Scientific in Q2 2013 and held it in 4 quarters.
Oak Associates's Boston Scientific position peaked at $2.48M in Q1 2014.
436 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2014.

Based on Oak Associates's 13F filing for Q3 2014, filed 16 Dec 2014.